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MITOMYCIN C : AN ANALYSIS OF ITS CYTOTOXICITY THROUGH 
STUDIES USING AN ANALOGUE DECARBAMOYL MITOMYCIN C 
Susie Young Kim 
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1994 
Hypoxic regions in solid neoplasms have been associated with tumor recurrence 
and resistance to various forms of cancer treatment, including radiation therapy. Various 
strategies have been designed to target radioresistant cells, including the use of the 
bioreductive alkylating agent mitomycin C [MC], which has been shown to exert 
preferential cytotoxicity under hypoxic conditions in some cell lines. Analyses of the 
chemical mechanism of action of MC indicate that this drug can form cross-links with 
DNA, and it is currently thought that the bisadduct is the critical lesion responsible for the 
inhibition of DNA synthesis. Computer-generated models indicate that the MC adduct can 
fit snuggly into the minor groove of B-DNA, suggesting that it does not impose major 
distortion to the structure of the DNA molecule. Based on these observations, how can we 
explain the ability of MC to disrupt DNA synthesis as well as to exhibit preferential toxicity 
to hypoxic cells? 
Numerous studies on MC have been performed in both chemical and biochemical 
systems. Several analogues of MC have also been the subject of research. In order to gain 
additional insight regarding the role of cross-linkage in the production of cytotoxicity, the 
analogue decarbamoyl mitomycin C [DMC] has been studied. DMC is structurally identical 

to MC except for the replacement of the carbamoyl group at the C-10" position by a 
nonalkyating hydroxyl group. This structural alteration would be expected to result in 
functional changes which would prevent DMC from forming bisadducts with DNA. 
Chemical studies reveal that at least in chemical systems, DMC can produce only 
monoadducts. If indeed it is the MC-DNA cross-links which kill cells, it would be 
expected that DMC would produce less cytotoxicity than MC. Interestingly enough, results 
from tissue culture experiments suggest that DMC is at least as toxic as MC to the EMT6 
mouse mammary tumor and to the wild type AA8 Chinese hamster ovary [CHO] cell lines. 
To further investigate the cytotoxic nature of DMC, experiments were conducted 
using mutant CHO lines which have specific deficiencies in DNA repair. The UV4 and 
UV5 lines, which are hypersensitive to bulky monoadducts and crosslinks, were chosen to 
help delineate DMC's ability to produce cytotoxicity in these mutant phenotypes. The data 
revealed similar results for DMC and MC treatments, suggesting that in these biological 
systems DMC has a pattern of cytotoxicity and a potency that are similar to those of its 
parent compound mitomycin C. These observations strongly suggest that although 
crosslink formation by MC may partially account for its cytotoxicity, there may be another 
product, possibly a monoadduct that is generated by both DMC and MC, which also 
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The intimate relationship that is found in normal tissues between cells and their 
microenvironment is disrupted in solid neoplasms. Tumors are often characterized by 
abnormalities in blood flow, tissue oxygenation, nutrient supply, environmental pH, and 
bioenergetic status (Vaupel, 1989). A major focus of cancer research today relates to 
understanding the alterations which result from the malignant transformation of cells and 
the mechanisms by which neoplastic growth can be manipulated. Considerable research 
has been devoted to identifying characteristics that are unique to malignant cells which can 
then be exploited in selective antineoplastic therapy. 
The purpose of this thesis is to examine in detail one mode of attacking solid 
neoplasms. The experiments that have been performed relate to investigation of a class of 
alkylating agents called mitomycins, an unusual group of antibiotics which are capable of 
mono- and bi-functional DNA alkylation. I was interested in analyzing the mechanism of 
action of the mitomycins at the molecular level. To carry out this research, an analogue of 
mitomycin C [MC], decarbamoyl mitomycin C [DMC], was studied extensively through 
tissue culture experiments under aerobic and hypoxic conditions. This compound was first 
examined using the EMT6 mouse mammary cell line. Currently the cytotoxicity of 
mitomycin C is attributed mainly to its ability to crosslink DNA and thereby inhibit DNA 
synthesis. Since DMC possesses only one of the two proposed alkyating sites in MC, 
DMC was expected to produce less cell kill; the results, however, do not support this 
hypothesis. In order to study how the toxicity of DMC might be related to the DNA lesions 
it creates, further investigation was performed using Chinese hamster ovary [CHO] cell 
lines having various deficiencies in DNA repair. A discussion of possible explanations for 
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the ability of DMC to exert cytotoxic effects will follow the presentation of the experimental 
data. 
The remainder of the introduction will review topics pertinent to the research that 
will be presented. First, I will discuss hypoxia in solid tumors and its role in conferring 
radioresistance, the effects of hypoxia on radiotherapy, and the acidic environment that is 
characteristic of many tumor tissues. I will then review the concept of bioreductive agents 
and will discuss more specifically the mitomycins. The evolution of this class of drugs will 
be presented, as well as the current understanding of how these compounds function at the 
subcellular level. The analogue decarbamoyl mitomycin C will be described and discussed 
in further detail, since the focus of my research is centered around this molecule. 
Hypoxia in Solid Tumors 
With the advent of hybridoma technology and genetic engineering, a number of 
novel therapeutic agents have been developed. These include monoclonal antibodies 
conjugated with radionuclides, toxins, cytokines, enzymes, effector antibodies, 
immunotoxins, lymphocyte activated killer cells, and tumor infiltrating lymphocytes (Jain, 
1989). Yet these modalities face the same problem that has already confronted the existing 
chemotherapeutic drugs, namely inadequate penetration of these agents to malignant cells. 
Interestingly, it has been observed that most forms of cancer therapy are affected in some 
way by the poor vasculature that has been found to be associated with solid tumors 
(Denekamp, 1993, 1991, 1990). 
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In order for an anti-cancer agent to reach neoplastic cells, it must first enter the 
tumor circulation. Gullino and Grantham hypothesized in 1962 that the tumor vasculature 
consists of vessels recruited from the pre-existing network of the host vasculature as well 
as vessels resulting from the angiogenic response to cancer cells (Gullino & Grantham, 
1962). However, a key structural difference between normal and tumor vessels is that the 
latter are dilated, saccular, and tortuous, often containing tumor cells within the endothelial 
lining of the vessel wall (Jain, 1989; Jain, 1988). Also characteristic of the neoplastic 
process is that cells within these vessels proliferate at a slower rate than the rapidly dividing 
cancer cells. In addition, blood flow rates near the necrotic regions of tumors have been 
found to be low, whereas blood flow rates in the non-necrotic areas are variable and often 
substantially higher than those in surrounding normal tissues (Jain, 1988). Tumors have 
been shown to possess areas of high interstitial pressure, which has been correlated with a 
reduction in tumor blood flow and subsequent development of necrosis (Jain, 1989; Jain, 
1987; Young et al., 1950). Although the mechanisms responsible for intermittent blood 
flow in tumor tissue are not entirely clear, it is speculated that causative factors include 
vessel plugging by white blood cells, rouleaux formation of circulating tumor or red blood 
cells (Jain, 1989), collapse of vessels in areas of high tumor interstitial pressure (Sevick, 
1989), and spontaneous vasomotion in incorporated host arterioles, affecting flow in 
downstream capillaries (Reinhold, 1977; Intaglietta, 1977). Consequently, the vascular 
network becomes less dense and is reduced to a degree that creates a general rarefaction of 
the vascular bed. As a result of these modifications, there is diminished oxygen transport 
capacity with progressive tumor growth, leading to regional hypoxia and anoxia, as well as 
glucose depletion, in the neoplastic tissue. These conditions have been strongly implicated 
as the cause for cytolysis, necrobiosis, and necrosis (Vaupel, 1977). 
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The presence of hypoxic cells in solid tumors was first demonstrated 
radiobiologically by Powers and Tolmach in 1963 using transplantable mouse 
lymphosarcomas (Powers & Tolmach, 1963). Further studies have demonstrated that the 
vast majority of cancer tissues possess hypoxic cells, frequently constituting 10-20% of the 
total tumor tissue population (Moulder & Rockwell, 1984). The imbalance between 
oxygen consumption and availability in solid tumors results from the abnormal vasculature 
and the absence of adequate perfusion. Heterogeneity of oxygenation within these tumors 
has been demonstrated by studies using oxygen microelectrodes, hemoglobin saturation 
measurements, cytochrome c reduction, and nuclear magnetic resonance spectroscopy 
(Moulder & Rockwell, 1990; Vaupel et al, 1981). It has also been shown that the hypoxic 
cell fractions in many transplantable rodent tumor systems increase with tumor size 
(Moulder & Rockwell, 1984). 
As a result of poor vascularization, solid tumors possess viable, oxygen-deficient 
cells of two different classes - chronically and transiently hypoxic cells (Rockwell, 1992; 
Vaupel & Thews, 1974; Thomlinson & Gray, 1955). Hypoxic cells are thought to be 
capable of proliferating and causing tumor recurrence, in part due to the protective nature of 
an oxygen-depleted environment against radiotherapy or chemotherapy. Thus the presence 
of anoxic cells in solid tumors is regarded as a major obstacle to the currently available 
treatment modalities for solid neoplasms. 
4 

Hypoxia and Its Effects on Radiotherapy 
In 1923, Petri noted a relationship between radiosensitivity and the presence of 
oxygen from a study of the effects of radiation on vegetable seeds. About a decade later, 
Mottram reported that marginal cells of carcinomatous cell masses are more sensitive to y - 
radiation than centrally located cells, and hypothesized that these peripherally located cells 
have a more abundant oxygen supply because of closer proximity to blood vessels, which 
renders them more radiosensitive (Mottram, 1936). Thomlinson and Gray later published 
some astonishing results which have made a great impact on studies of tumor biology. 
Their histological study of fresh specimens of human bronchial carcinoma revealed that 
avascular tumor areas with a radius of 200 p or greater possessed necrotic centers which 
were surrounded by intact tumor cells. It appeared that these tumor cells could proliferate 
and grow actively only in close proximity to a supply of oxygen or nutrients from the 
stroma. It was concluded that oxygen concentration fell off rapidly with increasing 
distance from the blood capillaries which carried an abundant supply of oxygen. Cells 
situated in the region distant from the capillaries would be relatively resistant to radiation 
treatment due to their low oxygen tension and could thus provide a focus for subsequent 
tumor regrowth (Thomlinson & Gray, 1955). 
Further evidence that hypoxic cells can be an important source for tumor regrowth 
has subsequently been obtained. Transplanted tissues from necrotic tumor regions have 
been shown to be capable of producing malignancies with a relatively high frequency 
(Goldacre & Sylven, 1962). In addition, it has been reported that fragments of the Walker 
256 carcinosarcoma which were perfused for 56 hours with medium low in oxygen grew 
as well as transplants from well-oxygenated tumor tissue (Gullino, 1968). 
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These major discoveries triggered tremendous interest in oxygen as playing a 
critical role in radiotherapy. It is now known from in vitro studies that as the oxygen 
concentration increases, cells become progressively more sensitive to radiation, until in the 
presence of oxygen tensions of 20-40 torr, radiosensitivity plateaus, with cells becoming 
about three times as sensitive as under complete anoxia (Hall, 1988). Tumors contain cells 
at low oxygen concentrations, which are resistant to radiation while normal tissues are fully 
oxygenated, and fully radiosensitive. Research therefore has been focused on efforts to 
make tumor cells more amenable to the cytotoxic effects of radiation. Initially in the early 
1960's, there was a search for compounds which mimic oxygen in sensitizing tissues to the 
effects of X-rays (Hall, 1988). Presently the problem of radioresistance is being 
approached from various angles, including the use of radiation sensitizers and protectors, 
hyperthermia, anti-angiogenesis, and the use of bioreductive agents (Horsman, 1993). 
Environmental pH 
In addition to inadequate oxygenation resulting from poor vascularization, 
inadequate nutrient supply has also been observed in solid tumors (Crabtree & Cramer, 
1934; Mottram, 1936). It is thought that due to the high metabolic rate of these rapidly 
growing tumor cells, sufficient nutrient supply cannot be maintained. As Tannock and 
Steel had initially observed, cell death appears to be closely related to blood stasis, which 
may result from occlusion of vessels by thrombi, by mechanical pressure, or by a tendency 
for vessels which supply central tumor regions to be bypassed with formation of capillary 
shunts closer to the periphery (Tannock & Steel, 1969). Consequently there is a build-up 
of lactic acid and other acidic metabolites which causes lowering of the pH. This 
acidification of the microenvironment has been shown to inhibit cell proliferation, DNA 
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synthesis, and glycolysis (Cater & Phillips, 1954). Furthermore, lowering of the pH has 
been associated with a decrease in the radiosensitivity of mammalian cells, modulation of 
the cytotoxicity of certain anticancer agents, and enhancement of the cell killing effect of 
heat (Vaupel, 1989; Tannock & Rotin, 1989; Kennedy, 1987). 
In rodent tumors, the pHs measured using microelectrodes vary from 5.80 to 7.52, 
and both intratumor and intertumor heterogeneity have been observed (Wike-Hooley et al., 
1984). Similar measurements made on the EMT6 tumors have demonstrated regional 
heterogeneity in pH, with values ranging from 5.8 to 7.6 (Rockwell et al., 1991). Studies 
on human tissue have shown that while normal human tissue usually has pH values 
between 7.0 and 7.4, human tumors can exhibit pH values as low as 6.15 (Vaupel, 1989; 
Wike-Hooley etal., 1984). 
Bioreductive Alkylating Agents 
In the 1930's, anaerobic cultures of microbes revealed that as cultures under either 
aerobic or anaerobic conditions grow and became more crowded, the redox potential of the 
microbial cultures decreases (Hewitt, 1936; Porter, 1964). By analogy, it has been 
hypothesized that hypoxic cells remote from the vasculature of a tumor mass might have a 
greater capacity for reductive reactions than their normal well-oxygenated counterparts 
(Kennedy, 1980), and therefore may be more sensitive to bioreductive alkylating agents 
(Sartorelli, 1988). 
Two classes of agents are presently known to exhibit preferential cytotoxicity 
toward hypoxic cells through reductive activation: the quinone bioreductive alkylating 
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agents such as mitomycin C [MC], BMY-42355, and EO-9, and the nitroaromatic 
heterocyclic hypoxic cell sensitizers such as misonidazole and metronidazole. The action of 
these compounds is very dependent on the microenvironment, as evidenced by the 
prerequisite of reductive activation in order to produce their cytotoxic effects (Rockwell, 
1992; Sartorelli, 1988; Kennedy et al., 1980; Moore, 1977). In a reciprocal manner, the 
cell's ability to tolerate alterations in cell physiology produced by the chemical perturbation 
will dictate the outcome of the effects of these drugs. 
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Mitomycin C : Chemical Strucure and Cytotoxic Activity 
The mitomycins, which were first isolated from Streptomyces caespitosus in 1956 
by Hata and co-workers (Hata et al, 1956), interestingly possess antimicrobial (Kinoshita 
et al., 1971) as well as antitumor activity (Crooke & Bradner, 1976). Several additional 
compounds which were subsequently isolated (Wakaki et al., 1958; De Boer et al., 1961) 
were found to be similar in structure and activity, and were therefore grouped and classified 
together as mitosanes. From this group of compounds, mitomycin C [MC] has been the 
most extensively studied. Its chemical structure was confirmed by structural analysis 
(Stevens et al., 1964) and is illustrated in Figure 1. MC possesses three major functional 
groups: the quinone, the carbamate, and the aziridine ring (Teng et al., 1969). 
Early studies on the mechanism of its action as an antibiotic revealed that MC can 
inhibit DNA synthesis in bacterial cells (Sekiguchi & Takagi, 1959; Shiba et al., 1959) and 
in mammalian cells (Sekiguchi & Takagi, 1960; Shatkin, 1962). Analysis using cesium 
chloride and cesium sulfate equilibrium density centrifugation enabled Iyer and Szybalski to 
hypothesize that inhibition of DNA synthesis by MC resulted from the cross-linking of 
complimentary strands of DNA (Iyer & Syzbalski, 1963). It has been demonstrated that 
MC is not active in its quinone form, but requires activation by enzymatic or chemical 
reduction (Iyer & Szybalski, 1963), or by mild acidic treatment (Tomasz, 1979). It is only 
after activation that MC can alkylate DNA to yield both mono- and bi-functional convalent 
adducts; because of this unique mechanism of action, MC has been referred to as the 




FIGURE 1. The Chemical Structure of Mitomycin C 
Mitomycin C possesses three major functional groups: the quinone, the carbamate, and the 
aziridine ring. The drug is not active in the quinone form, but must first undergo 
bioreductive activation. Analogues of mitomycin C which have alterations in one or more 
of these functional groups, such as decarbamoyl mitomycin C, have been analyzed in order 




Upon further analysis of its cytotoxic effects, it has also been demonstrated that MC 
creates single-strand breaks in bacterial DNA (Otsuji & Murayama, 1972). Investigation 
on mammalian DNA by alkaline elution, however, has not shown that single-strand or 
double-strand breaks are produced, which suggests that MC does not kill mammalian cells 
by generating oxygen free radicals, but instead acts primarily by alkylation when used 
within the pharmacological range (Dorr et al, 1985; Pristos, 1986). Although these 
conclusions may appear contradictory, MC could actually exert its toxicity via two differed 
mechanisms (Kennedy et al, 1981; Satorelli, 1988). First is its oxygen-dependent 
toxicity, which is proposed to occur by cyclic one-electron reduction of MC followed by 
oxidation by molecular oxygen to produce the original MC molecule and a superoxide 
radical (Bachur et al, 1978, 1979). The second mechanism is thought to involve 
bioreductive activation of the MC molecule to a highly reactive bifunctional alkylating 
species (Iyer & Szybalski, 1963, 1964). Further investigation on the molecular damage 
produced by MC has been performed by analysis of mutations at the hprt locus of Chinese 
hamster V79 cells induced by MC (Davies, 1993); these experiments revealed that MC can 
produce total, partial, and point deletions on the hprt gene, suggesting that, at the molecular 
level, the alterations created by MC are possibly multilocus deletions. 
The increased sensitivity to MC of hypoxic cells over their oxygenated counterparts 
has been attributed to the fact that oxygen decreases the formation of the reduced 
intermediate responsible for the production of what is presently considered to be the 
primary cytotoxic lesion, namely the cross-linking of DNA (Sartorelli, 1988). With the 
knowledge that some solid tumors contain hypoxic regions resistant to radiation, this 
concept of using this preferential cytotoxicity to hypoxic cells has since been applied by 
combining MC and radiotherapy (Rockwell, 1993, 1992). The ability of the mitomycin 
antibiotics to eradicate hypoxic cells in solid tumors has been noted in well-established 
implants of the EMT6 mammary sarcoma in BALB/c mice (Keyes et al, 1985; Rockwell, 

1983; Teicher et al., 1981; Kennedy et al., 1981; Kennedy et al., 1980). Cell culture 
experiments on the effects of MC combined with radiation have produced data which 
indicate that the shape of the MC survival curve is not changed by irradiation, nor does the 
addition of MC alter the shoulder or slope of the radiation dose-response curve. Hence in 
vitro studies suggest that mitomycin C does not sensitize EMT6 cells to X-irradiation, and 
that these two modalities behave in an additive fashion (Rockwell et al., 1985; Rockwell, 
1982). 
Studies on mitomycin C have been conducted under a number of conditions, 
including several chemical and biochemical systems, and cell cultures derived from normal 
and malignant tissues from humans and animals, as well as tumors and normal tissues of 
experimental rodents. Clinical trials on patients with various malignancies have also been 
conducted with MC and with another one of its analogues, porfiromycin. Although data 
generated from these various experiments provide useful information, interpretations must 
be made with caution, since each system possesses intrinsic differences which may 
influence the results. 
Mitomycin C : Bioreductive Activation 
In order to produce cytotoxicity, mitomycin C must first undergo activation (Lin et 
al., 1972; Schwartz et al, 1963). The C-l and C-10 positions of the compound (refer to 
Figure 1) are considered to be masked alkylating functions which become allylic, and hence 
activated, upon reduction of the quinone system (Tomasz et al., 1988a). Previous studies 
have shown that enzymatic systems which activate these quinones and produce oxygen 
radicals include the NADPH-cytochrome c reductase, xanthine oxidase, and intact 

mitochondria (Pristos & Sartorelli, 1986). Activation apparently occurs either via a one- 
electron reduction to produce a semiquinone or via a two-electron reduction to form a 
hydroquinone (Patrick et al., 1964). In the mammalian system, the anaerobic metabolism 
of MC has been shown to be increased two-fold by the addition of cytochrome P-450 to the 
NADPH-cytochrome c reductase reaction mixture; it is thought that this action results from 
modulation of the activity of NADPH-cytochrome c reductase by the cytochrome P-450 
(Sartorelli, 1988). 
Figure 2 illustrates possible mechanisms by which MC undergoes activation. In 
1966, Murakami (1966) postulated that one-electron reduction of the mitomycins to the 
semiquinones was important for DNA cross-linking. This creates a structural change in the 
nucleotide bases corresponding to their tautomeric isomers, particularly for cytosine and for 
guanine as compared to thymine and to adenine. It has been suggested that the 
semiquinone form is the active intermediate which cross-links the O6 position of guanine 
and the N-4 of cytosine to the N-4 and 0-5 of mitomycin. Other investigators have 
supported the existence of the semiquinone form with direct evidence by esr spectroscopy 
and by electron paramagnetic resonance spectrometry (Patrick et al., 1964; Nagata & 
Matsuyama, 1969; Lown et al., 1978; Bachur et al., 1979; Kalyanaraman et al., 1980). 
Furthermore, it has been proposed that following the single-electron reduction, reoxidation 
of MC may occur in the presence of oxygen to generate a superoxide radical, which may 
dismute to hydrogen peroxide and to other radicals known to be cytotoxic (Fridovich, 
1972). There is also evidence supporting the two-electron reduction of the mitomycins 
(Workman & Stratford, 1993; Patrick et al., 1964; Iyer & Szybalski, 1964). Studies from 
tissue culture experiments support the fact that the oxygen radicals may contribute to the 
aerobic cytotoxicities of some mitomycins (Pristos et al., 1989) but do not explain the 




FIGURE 2. Possible Mechanisms for the Activation of Mitomycin C 
Mitomycin C is initially reduced and alkylated to yield a monoadduct species 8". This 
intermediate subsequently enters one of two pathways. The monofunctional activation 
pathway is taken via electron transfer to unreacted MC, which occurs predominantly when 
the reduction rate is slow. The bifunctional pathway is taken via retro-Michael elimination 
of the C-10" carbamate to yield end products designated 7 and 9. Chemical studies 
suggest that reduction kinetics, rather than redox potentials, as the critical factor in 
determining the pathway for the activation of mitomycin C. (Reprinted with permission, 
Tomasz etal., 1988). 
Monofunctionai Adduct 7“ Crosslink adduct 9 ~ 
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Additional studies have suggested that the binding of MC to DNA is more 
dependent upon the semiquione form of the activated compound than upon the 
hydroquinone (Tomasz et ai, 1974). More recently, it has been observed that MC can also 
be activated solely by an acidic environment, an interesting observation in regal'd to the fact 
that lower pHs have been noted in many tumor tissues relative to normal tissue (Tomasz, 
1979). 
Mitomycin C : Mechanism of Action 
The mechanism of action of MC has been investigated since the 1960's, when Iyer 
& Szybalski proposed both mono- and bi-functional alkylation by this agent. Tomasz and 
co-workers studied the adduct formation resulting from monofunctional and bifunctional 
activation in the chemical systems by treating DNA from Micrococcus luteus with MC and 
by analyzing the adduct distribution by high performance liquid chromatography (Tomasz 
et al., 1988a,b). The proposed mechanism is diagrammed in Figure 3 and is outlined as 
follows: reduction of the quinone to the hydroquinone with elimination of the methoxy 
group, opening of the aziridine ring by an elimination process to yield a C-l quinone 
methide, nucleophilic addition of DNA to the quinone methide to give a monoalkylated 
adduct, followed by intramolecular SN2 displacement of the carbamate to form a second 
quinone methide at C-9, thereby yielding a cross-linked adduct (Moore & Czemik, 1981). 
After the sequential activation of the C-l and C-10 positions of MC, covalent bond 
formation is thought to be preceded by a noncovalent association, presumably of the 
intercalative type, between the MC semiquinone and DNA. Alkylation of DNA by MC has 
been demonstrated to be exquisitely specific, with determination of the alkylation site to be 
solely at the N2 position of guanine (Bizanek, 1993). According to these results, the ratio 


FIGURE 3. The Mechanism of Action of Mitomycin C 
The proposed mechanism of action is outlined as follows: reduction of the quinone to the 
hydroquinone with elimination of the methoxy group, opening of the aziridine ring by an 
elimination process to yield a C-l quinone methide, nucleophilic addition of DNA to the 
quinone methide to give a monoalkylated adduct, followed by intramolecular SN2 
displacement of the carbamate to form a second quinone methide at C-9, thereby yielding a 
cross-linked adduct. (Reprinted with permission, Tomasz et al, 1988). 
o 
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of mono- to bi-functional adducts, previously determined to be in the order of 10:1 
(Tomasz et al., 1974), is largely dependent on the DNA base sequence. These 
investigators also report that the critical factor in determining this ratio appears to be 
reduction kinetics rather than redox potentials. Further analyses of MC binding to DNA 
have also suggested that the local DNA structure plays a critical role in determining the 
efficiency of cross-link formation (Basu et al., 1993; Cera & Crothers, 1989; Teng et al., 
1989). 
Iyer and Syzbalski showed that crosslinks between MC and DNA are formed and 
are stable during treatment with heat, alkali, formamide, and in a cesium chloride gradient 
(Iyer & Szybalski, 1964), but direct evidence for the existence of these complexes was not 
available for some time. There were several reasons for the difficulty in isolating the DNA- 
MC complexes, including the necessity for having to activate the compound in vitro and 
the fact that adduction of MC to DNA in vitro occurs at a rate of only one MC molecule per 
several hundred nucleotides (Weissbach & Lisio, 1965). However, the first direct proof of 
a DNA cross-link adduct with MC was reported in 1987, with isolation of two other 
adducts following immediately (Tomasz et al., 1987; Tomasz et al., 1988a,b). The 
structure of the bisadduct was determined by spectroscopic methods including proton 
magnetic resonance, differential Fourier transform infrared spectroscopy, and circular 
dichroism. Computer-generated models of the bisadduct incorporated into the center of the 
duplex synthetic B-DNA decamer d(CGTACGTACG)2 indicated the stereochemical fit of 
this adduct to be in the minor groove with minimal distortion of the DNA structure. 
Analysis of factors influencing monofunctional versus bifunctional activation again 
suggested that the critical factor is reduction kinetics, rather than reduction 
thermodynamics. There is continued evidence suggesting that one-electron reduction is 
sufficient to activate both electrophilic MC centers, at the C-l and C-10 positions. 
20 

The products which result from mitomycin C -DNA interaction have been identified 
in a subcellular system as 2 monoadducts and 2 bisadducts; the bisadducts reflect both 
DNA-interstrand and intrastrand crosslinks (Bizanek et al., 1992; Tomasz et al., 1988a,lr, 
Tomasz et al., 1987; Tomasz et al., 1986). Only recently have these entities been detected 
in vivo. A group in Japan has successfully synthesized [3H]-labelled MC, which was used 
by Bizanek and colleagues on EMT6 mouse mammary tumor cells in the isolation and 
identification of MC-DNA adducts in vivo (Bizanek et al., 1993). Analysis of these 
adducts indicated that the adducts found in living cells were identical to the ones which 
were previously isolated from chemical studies. 
Decarbamoyl Mitomycin C 
To further investigate the chemical mechanism of action of MC, analogues of MC 
with minor structural alterations have also been examined (Weiss et al., 1968). One of 
these is decarbamoyl mitomycin C [DMC], which differs from its parent compound in that 
the C-10" carbamate is replaced by a hydroxyl group. DMC is synthesized from MC by 





FIGURE 4. The Stucture of Decarbamoyl Mitomycin C 
The analogue decarbamoyl mitomycin C is structurally identical to that of MC except that 
the carbamyl group at the C-10" position of MC is substituted by a hydroxyl group, a 









Because of mounting interest in correlating the cytotoxicity of MC with its ability to 
form cross-links, its analogue DMC has been studied in various systems. Experiments 
performed on DNA from E. coli have suggested that DMC is not able to form cross-links 
(Otsuji & Murayama, 1972). The DNA lesions produced by DMC were also studied in 
Fanconi's anemia cells, as well as lymphocytes from Fanconi's anemia patients, and the 
results from alkaline sucrose profiles further support the monofunctional activity of DMC 
and its inability to form cross-links (Sasaki,1975; Fujiwara & Tatsumi, 1977). 
Further investigation was performed using the sister-chromatid exchange (SCE) 
assay, a sensitive and quantitative measure of genetic alteration which is determined by an 
increase in frequency of exchange when cells are exposed to mutagens or to carcinogens. 
Carrano and co-workers treated Chinese hamster ovary cells with either MC or with DMC 
and found that DMC was actually a more potent inducer of SCE than MC (Carrano et al., 
1979). After drug treatment, DNA samples from the cells were denatured and bound to 
hydroxyapatite chromatography; in those samples that were treated with DMC, essentially 
all radioactivity was recovered, indicating that only single-strand adducts, rather than 
double-strand crosslinks, were produced. 
The molecular reaction of DMC has also been analyzed through studies using DNA 
from Micrococcus lutueus and a chemical reduction system with sodium dithionite 
reduction. Once again DMC was observed to form strictly monoadducts from analysis of 
its products by high performance liquid chromatography (Tomasz et al., 1988). Data from 
these experiments suggest that displacement of the C-10" leaving group is a critical step in 
the bifunctional pathway, and that DMC lacks the bifunctional potential. If indeed the 
cross-linking ability of MC accounts for most of its cytotoxicity, then DMC should be less 
cytotoxic than MC. 

Materials and Methods 
Drugs 
Mitomycin C was provided without cost by Bristol Myers Squibb (Wallingford, 
CT). Lyophilized decarbamoyl mitomycin C was generously provided by Maria Tomasz 
(Department of Chemistry, Hunter College). The identity of DMC was reconfirmed by 
mass spectrophotometry at The Yale Comprehensive Cancer Center and the purity of the 
DMC sample was determined by TLC using a 5:1 mixture of acetoneichloroform solvent. 
The compounds were protected from light in order to prevent photodegradation. The drugs 
were dissolved in small volumes of sterile 70% ethanol to produce stock solutions of 
various drug concentrations which in the experiments were further diluted in culture 
medium. 
Cells 
In order to study the structure and properties of solid tumors, several model 
systems have been proposed and utilized for experimental oncology. The simplest of these 
are exponentially growing monolayer cultures of tumor cells. It has been known for some 
time that density-inhibited cultured cells (plateau phase) and populations of solid tumor 
cells in vivo share many properties. More specifically, both groups contain large fractions 
of out-of-cycle but potentially clonogenic cells which constitute a major obstacle to the 
successful treatment of many solid tumors (Hahn et al., 1968; Hahn & Little, 1972; Ray et 
al., 1973). Noncycling cells include those that cannot produce new cells and are therefore 
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considered to be clonogenically non-viable, as well as clonogenically viable cells, which 
can proliferate if stimulated by an environmental change. Quiescent cell populations are 
thought to occur in adequately perfused regions within tumors (Tannock, 1978), and have 
been shown to be less radiosensitive than their aerobic counterparts (Kallman et al., 1980). 
Because exponentially growing and plateau phase cultures have similar responses 
(Rockwell, 1983), only exponentially growing cultures were used in these studies. 
The development of the colony formation assay in 1955 has allowed for the 
measurement of the survival of cells treated in vitro with radiation, drugs, and other agents 
(Puck & Marcus, 1955). An ingenious system developed for experimental oncology is the 
in vivo-in vitro tumor system, which is based upon transplanted tumor cell lines that have 
been adapted to or selected for growth in cell culture. Unique to the in vivo-in vitro model 
is that it allows detailed examination of the effects of therapeutic agents on tumor cell 
populations in vivo and in vitro by colony formation assay with a quantitative precision that 
is not possible with older animal tumor models (Rockwell, 1977). This system therefore 
allows in vitro assaying of clonogenic cells suspended from tumors that are treated in vivo . 
The EMT6 in vivo-in vitro tumor system was developed by Dr. Rockwell using a 
mouse mammary tumor originally developed from mamary tumor KHJJ (Rockwell, 1977, 
1973). This system has been utilized in the past to study mitomycin C and its N-methyl 
derivative, porfiromycin [POR]. In the studies which are presented in this thesis, the first 
set of experiments analyzing MC and DMC, utilized this system. 
Further examination of the mitomycins was then performed on another set of cell 
lines derived from Chinese hamster ovary [CHO] cells. The wide use of CHO cells is 
mainly atttributed to the fact that these cells grow well and have a high plating efficiency 
(Hahn et al., 1968; Stewart et al., 1968; Hickson & Hands, 1988). To gain a better 
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understanding of the relationship between DNA damage and DNA repair, cell survival and 
mutation, a series of DNA repair-deficient mutants of Chinese hamster ovary cell lines has 
been developed and studied. The general approach in these studies has been to mutagenize 
the parent population with radiation or with an alkylating agent, to screen for isolates 
hypersensitive to a particular DNA-damaging agent, and to examine the hypersensitive 
sublines (Hickson & Harris, 1988). Hoy, Thompson, and other colleagues have identified 
DNA repair-deficient mutants from five genetic complementation groups isolated from 
Chinese hamster cells (Hoy et al., 1984; Hoy et al., 1985). From their studies they 
characterized and isolated two mutant strains with deficiencies in removal of mono- and bi¬ 
functional adducts; the UV4 mutant line has the lowest efficiency in removing cross-links, 
where the UV5 subline has intermediate efficiency. Testing of 22 different alkylating 
agents on these two mutant lines have suggested that sensitivity is determined by cross¬ 
links, and not by the monoadducts that are produced (Hoy et al., 1985). 
EMT6 mouse mammary tumor cells (suhline EMT6/Rw) 
The first set of experiments with mitomycin C IMC] and with decarbamoyl 
mitomycin C [DMC] was performed using EMT6 mouse mammary tumor cells (subline 
EMT6/Rw). Stock cultures of this line were seeded at a concentration of 1 x 106 cells and 
grown as monolayers in T-25 flasks (25 cm2 plastic tissue culture flasks. Falcon). This 
line was propagated in 10 ml of Waymouth's medium (Hazelton) which was supplemented 
with 15% fetal bovine serum (Gibco) and antibiotics (fungizone, gentamycin, penicillin, 
and streptomycin, all from Gibco). Cultures were grown in a 37°C incubator with a 
humidified atmosphere of 95% air/5% CO2. With a doubling time of 12-14 hrs (Rockwell, 
1977), these monolayers were subcultured every 3 - 4 days. 
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Chinese hamster ovary cell lines AA8. UV4. and UV5 
The next set of tissue culture experiments was on the AA8, UV4, and UV5 lines of 
Chinese hamster ovary [CHO] cells, which were obtained from Dr. Larry Thompson at 
Lawrence Livermore National Laboratory. Stock cultures of these lines were seeded at a 
concentration of 1 x 104 cells and grown as monolayers in T-25 flasks (25 cm2 plastic 
tissue culture flasks. Falcon). These lines were propagated in 10 ml of alpha-Minimum 
Essential Medium (a-MEM, Gibco) which was supplemented with 10% fetal bovine serum 
and antibiotics (fungizone, gentamycin, penicillin, and streptomycin, all from Gibco). 
Stock cultures were subcultured every 7 days and were grown in a 37°C incubator in a 
humidified atmosphere of 95% air/5% CO2. The doubling time of these monolayers was 
20 hours. 
Cell Culture Studies 
In setting up cells for the experiments which compared the sensitivity of fully 
aerobic and fully hypoxic cells in vitro to the drugs, the monolayers were washed with 5 
ml of 0.05% trypsin followed by trypsinization with 5 ml of the trypsin for about 10 
minutes. The proteolytic action of the enzyme was then neutralized with 5 ml of serum- 
supplemented medium, Waymouth for the EMT6 cells and a-MEM for the CHO cell lines. 
Cells were gently pipetted into single-cell suspensions and were counted using a Coutler 
Counter Model ZBI (Rockwell, 1977). Cultures were set up by plating 2 x 105 cells into 
glass milk dilution bottles; these flasks also contained 10 ml medium which had been pre¬ 
equilibrated for at least one hour in a 37°C humidified incubator to attain optimal pH and 
temperature for cell growth. Once the cells were seeded, they were allowed to grow for 3- 
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4 days in a humidified atmosphere of 95% air/5% CO2 at 37°C. On the day of drug 
treatment, the medium was replaced with 5 ml of fresh medium (Waymouth for the EMT6 
cells and a-MEM for the CHO cell lines). At this point, the flasks were divided into 2 
groups, one exposed to the drug in an aerobic environment and the other treated under 
hypoxic conditions. 
The hypoxic apparatus was set up such that a gas mixture of 95%N2/5%C02 
(containing < 10 ppm O2) was warmed and humidified by bubbling through a Corning 
humidifier containing degassed H2O. To eliminate all oxygen in the hypoxic apparatus, the 
system was flushed with the N2/CO2 gas mixture for one hour before treatment of the 
cultures. 
When the cultures were to be exposed to the hypoxic environment, the caps on the 
flasks were removed and the glass bottles were stoppered with tight-fitting rubber sleeves. 
One 13-gauge and one 18 gauge needle were inserted through the septum of each rubber 
stopper. The humidified mixture of 95%N2/5%C02 was made to flow through the flasks 
by attaching the plastic tubing of the hypoxic system to the 13 gauge needle as previously 
described (Kennedy, 1980; Rockwell, 1988). In this system, outflow from the gassed 
flasks was through 18-gauge needles connected to rubber tubing whose ends were 
submerged in degassed H2O. This allowed visual monitoring of gas flow by continuous 
bubbling of H2O, and it also prevented backflow of air into the culture flasks. Previous 
studies have shown that this method produces severe hypoxia after 1 hour (Kennedy, 
1980; Rockwell, 1988). Cultures for the experiments presented in this thesis were gassed 
with N2/CO2 for 2 hours prior to drug treatment. 
The cell cultures were treated with graded doses of drug for 1 hr. Cells which were 
exposed to the aerobic environment were treated with the drug at 37°C. To treat the 
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cultures in hypoxia, the drugs at various concentrations were injected through the septums 
of the rubber stoppers while maintaining an anaerobic environment; this procedure did not 
introduce sufficient oxygen to alter the radiosensitivity of the hypoxic cells and did not alter 
the pH of the culture medium (Rockwell, 1988). 
At the end of the drug treatment, the medium which contained the drug was 
removed, and the cells were washed with 5 ml of 0.05% trypsin and trypsinized with 5 ml 
of the trypsin for about 10 minutes. Following neutralization with 5 ml of medium, the 
single cell suspension was then counted on the Coulter Counter Model ZB I (Rockwell, 
1977). Three to four dilutions were made and plated at low densities in quadruplicate in 60 
mm2 plastic tissue culture dishes (Costar). These dishes contained 5 ml medium which had 
been pre-equilibrated in a 37°C incubator overnight. After plating, the culture dishes were 
returned to the 37°C incubator for colony formation assay to assess cell viability. 
Cell Survival Studies 
The EMT6 cell culture experiments were incubated for 14 days and the CHO cell 
lines for 7 days at 37°C to allow viable cells to grow into macroscopic colonies. On day 14 
and day 7 for the EMT6 and CHO cell line experiments, respectively, the growth medium 
was removed and the cultures were washed with 0.9% saline solution. The colonies were 
fixed and stained for 20 minutes with a solution of crystal violet in formyl methanol. Only 
colonies containing more than 40 cells were counted; the number of colonies per plate was 
calculated from the average of the colony counts of the set of four dishes that had been 
seeded in quadruplicate. Surviving fractions for treated cultures were calculated using 
plating efficiencies of untreated controls assayed on the same day. Vehicle-treated controls. 
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subjected to all of the experimental conditions and treated with maximal concentrations of 
sterile 70% ethanol, were also included in each experiment and were used to assess and to 
correct for any cytotoxic effects from the experimental manipulations. 

Results 
The effects of mitomycin C [MC] and decarbamoyl mitomycin C [DMC] were 
examined under hypoxic and aerobic conditions using the EMT6 cell line, and subsequently 
the Chinese hamster ovary cell lines AA8, UV4, and UV5. Survival curves were generated 
in order to: (1) compare the cytotoxicity of DMC to the various cell lines, (2) evaluate the 
relative cytotoxicity of DMC to aerobic and hypoxic cells, and (3) compare the cytotoxicity 
of DMC to that of its parent compound MC. All of the studies using DMC were performed 
under similar conditions, with one hour drug treatments at varying drug concentrations. 
Although the major focus of this thesis is on the analysis of the effects of DMC on cell lines 
deficient in DNA cross-linkage repair, data from these studies can also be used to compare 
the cytotoxicity of DMC with the effects of the other mitomycins. Previous studies on the 
MC toxicity in some CHO cell lines have analyzed MC at a given drug concentration with 
different times of drug exposure, and the results are reprinted in this thesis with permission 
(Hughes et al„ 1991). Although the experimental design differs slightly from the studies 
conducted for this thesis, comparisons can be made with previous results given the fact that 
antecedent studies have demonstrated that the most important parameter in determining the 
overall cytotoxicity of MC is the concentration times the duration of drug exposure 
(Hughes et al., 1991; Marshall & Rauth, 1988). 
Effects of MC and DMC on EMT6 Cells 
The results from exposure of EMT6 cells to DMC under aerobic and hypoxic 
conditions at the time of drug exposure are graphed in Figure 5. Figure 6 compares the 
response of the EMT6 cells to MC and to DMC under aerobic and hypoxic conditions at the 


FIGURE 5. Survival of EMT6 Cells After Treatment With DMC Under 
Aerobic and Hypoxic Conditions. The EMT6 cell line was exposed to one hour drug 
treatment with DMC at various concentrations. Each point represents the mean of three to 
five independent determinations +/- SEMs (standard errors of the mean). Key: closed 
circles represent aerobic conditions, and open circles represent hypoxic conditions. 
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FIGURE 6. Survival of EMT6 Cells After Treatment With MC and DMC 
Under Aerobic and Hypoxic Conditions. Each point represents the mean from two 
to five independent determinations. SEMs are shown for points based on three or more 
determinations. Key: closed symbols represent aerobic conditions and open symbols 
















time of drug exposure. Data obtained from treatment of this cell line with MC in these 
experiments are similar to those reported in earlier studies (Kennedy et ah, 1980, Keyes et 
ah, 1984, 1985; Rockwell, 1983, 1986). The toxicity of DMC is surprisingly similar to 
that of MC, as suggested by the similarity in the survival curves. Furthermore, both 
compounds appear to confer preferential cytotoxicity towards hypoxic cells. 
The Effects of MC and DMC on the CHO Cell Lines 
Because the identity of the toxic lesion(s) could potentially vary with the cell line 
and the cellular environment (Keyes et ah, 1984, 1985 a,b\ Lown et ah, 1976; Tomasz, 
1979; Underberg & Lingeman, 1983), MC and DMC were also tested on another cell line, 
the Chinese Hamster Ovary [CHO] cell line AA8. This particular CHO cell line was 
chosen due to the availability of several mutant sub-strains which possess specific defects 
in DNA repair (Hoy 1984; Hoy et ah, 1985). The AA8 cell line was therefore an important 
system to study, because comparisons between AA8 and the mutant strains would facilitate 
in elucidating the cytotoxic lesions that are produced by DMC and MC. Figure 7 shows 
the results from treatment of the wild type AA8 CHO line with DMC under aerobic and 
hypoxic conditions. In comparing the data from the AA8 line with those from the EMT6 
cells (see Figure 6), the cytotoxic effects of DMC appear to be similar on both cell lines. 
The effects of MC on the AA8 cell line are graphed in Figure 8 with permission. 
Comparing the graphs in Figures 7 and 8 suggest that MC and DMC have similar effects on 




FIGURE 7. Survival of AA8 Cells After Treatment With DMC Under 
Aerobic and Hypoxic Conditions. The AA8 cell line was exposed to one hour drug 
treatment with DMC at various concentrations. Each point represents the mean from two to 
five independent determinations +/- SEMs. Key: closed circles represent aerobic 
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FIGURE 8. Survival of AA8 Cells After Treatment With MC Under 
Aerobic and Hypoxic Conditions. The AA8 cell line was exposed to one hour drug 
treatment with MC at various concentration. Each point represents the mean of three to five 
independent determinations +/- SEMs. Key: filled triangles represent aerobic conditions, 
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The DNA repair-deficient sub-strains UV4 and UV5, derived from the AA8 line, 
were used to examine more closely the cross-linking ability of the mitomycins. Results 
from treating the UV4 mutant line with DMC are shown in Figure 9, and results from 
treatment with MC are presented in Figure 12. Data from treatment with MC have been 
reprinted with permission from Dr. Christine Hughes (Hughes et al., 1991). Previous 
studies indicate that the UV4 strain is very sensitive to MC under aerobic and hypoxic 
conditions. The current results suggest that DMC exerts cytotoxicity similar to that of MC 
on the UV4 cells. However, the sensitivity of these cells to DMC is more pronounced 
under hypoxic conditions. It should be noted that the concentrations of both MC and DMC 
used to treat the UV4 line were diluted 10-fold lower than the concentrations to which the 
wild type cells were exposed. 


FIGURE 9. Survival of UV4 Cells After Treatment With DMC Under 
Aerobic and Hypoxic Conditions. The UV4 cell line was exposed to one hour drug 
treatment with DMC at various concentrations. Each point represents the mean of two to 
four independent determinations. SEMs are shown for points based on three or more 
determinations. Key: filled squares represent aerobic conditions and unfilled squares 
















DMC was tested on the other DNA repair-deficient mutant line, UV5, and the results are 
graphed in Figure 10. Data from treatment of this mutant strain with MC are reprinted in 
Figure 12 for comparison (Hughes et ai, 1991). Previous studies with MC on the UV5 
line indicate intermediate sensitivity to the effects of this alkylating agent, and futhermore 
no real differential toxicity between drug exposure under aerobic or hypoxic conditions has 
been observed. Interesingly enough, DMC also appears to exert intermediate cytotoxic 
effects on this particular mutant strain, with no obvious preferential hypoxic cell kill. The 
magnitude of the hypoxic/oxic differential for both MC and DMC thus appears to be much 




FIGURE 10. Survival of UV5 Cells After Treatment With DMC Under 
Aerobic and Hypoxic Conditions. The UV5 cell line was exposed to one hour drug 
treatment with DMC at various concentrations. Each point represent the mean of two to 
five independent determinations. SEMs are shown for points based on three or more 
determinations. Key: filled diamonds represent aerobic conditions, and unfilled diamonds 

















To facilitate the comparison of the effects of decarbamoyl mitomycin C on the mutant 
strains relative to its cytotoxicity to the AA8 cell line, the combined results from treatment 
with DMC on the AA8, UV4, and UV5 cells are graphically depicted in Figure 11. 




FIGURE 11. Survival of AA8, UV4, and UV5 Cells After Treatment With 
DMC Under Aerobic and Hypoxic Conditions. Graphs from figures 7, 9, and 10 
are plotted together in order to facilitate in comparing the effects of DMC on the wild type 
AA8 cell line to its effects on the mutant lines UV4 and UV5. Key: open symbols 















FIGURE 12. Survival of AA8, UV4, and UV5 Cells After Treatment With 
MC Under Aerobic and Hypoxic Conditions. The effects of MC on the CHO line 
AA8 and on its substrains UV4 and UV5 are represented in this graph. Key: open symbols 
represent aerobic conditions, and filled symbols represent hypoxic conditions. The data on 
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Chemical Analysis of the Compound DMC 
DMC was chemically synthesized from mitomycin C, and the purity of the sample 
was analyzed by mass spectrophotometry and by thin-layer chromatography [TLC]. Using 
the electrospray method, the mass spectrophotometry readout indicated a peak at 262 
consistent with the molecular weight of DMC. There were two other peaks of much higher 
molecular weight; these were too high to correspond to mitomycin C, but their identity 
remains unknown. One possibility is the dimerization of DMC. The major concern was 
possible contamination with MC, which would have produced a peak at 360; however, the 
results demonstrate that the sample was free of MC. The author wishes to thank Mr. 
Walter McMurray for running the sample through the mass spectrophotometer. 
Further analysis on the purity of the compound was performed by thin-layer 
chromotography. Using the solvent system containing 5:1 acteonexhloroform, the average 
Rf ratios obtained were : 6.0 for DMC, 5.5 for DMC:MC mixture, and 5.0 for MC. There 
was no evidence for MC contamination in the DMC sample. The author wishes to thank 
Dr. Juliang Zhu for helping set up the TLC system. 

Discussion 
Analysis of the effects of decarbamoyl mitomycin C on several cell lines have 
yielded intriguing results which serve as a reminder of the complex nature not only of the 
chemistry of the mitomycins but also of the cellular response to such perturbations. 
Results from these experiments, particularly those with the DNA repair-deficient CHO 
strains, provide additional insight into the action of the mitomycins. This section of the 
thesis will integrate data from the DMC experiments with the current understanding of the 
antineoplastic effects of the mitomycins. 
Decarbamoyl mitomycin C is structurally identical to mitomycin C except for its 
lack of an alkylating group at the C-10" position. A strong correlation between interstrand 
crosslinks and cytotoxicity has been observed in dose-response studies with MC on 
various cell lines (Keyes et al., 1991; Dorr, 1985; Kohn, 1981; Kinoshita el al., 1971). 
The cytotoxic effects of mitomycin C have been attributed to its ability to crosslink DNA; 
hence the analogue DMC, previously shown to be incapable of forming bisadducts in 
chemical systems, was predicted to be less cytotoxic. Results from these experiments 
performed on four cell lines, EMT6, AA8, UV4 and UV5, suggest otherwise. 
Initial experiments with DMC have been performed on the wild type EMT6 and 
AA8 strains. Comparison of survival curves for DMC with those for MC suggest that 
DMC possesses activity similar to its parent compound, and demonstrate that DMC is 
preferentially cytotoxic to hypoxic cells. Because these results came as a surprise, there 
was concern for the possibility that DMC might be contaminated with MC. The DMC 
sample utilized in the experiments was therefore verified by mass spectrophotometry and 
by TLC methods to be free of MC. The outcome of these experiments raises several 
questions. First, with the prediction that DMC is less potent than MC, how is the 
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decarbamoyl analogue able to kill cells with similar efficacy as its parent compound? Also, 
could it be that lesions other than bisadducts, i.e. monoadducts, play a significant role in 
the production of cellular toxicity? Finally, is it possible that DMC produces crosslinks in 
vivo which have yet to be identified? 
To examine the possible relationship between monoalkylation and cytotoxicity, the 
cell lines UV4 and UV5, which possess deficiencies in DNA crosslink repair, were 
exposed to DMC. The mutant CHO line UV4 lacks the ability to remove DNA crosslinks 
and bulky DNA monoadducts, whereas the UV5 strain is not capable of removing bulky 
monoadducts, but still has an intact DNA-DNA crosslink repair mechanism (Hoy, 1984, 
1985). In the studies reported here, the results with the UV4 cells suggest that this mutant 
strain is very sensitive to both MC and DMC. It should be noted that the concentrations of 
the drugs used to treat this cell line were much lower than those used to treat the wild-type 
AA8 strain. While MC appears to exert similar effects on the aerobic and hypoxic UV4 
cells, sensitivity to DMC is more pronounced under hypoxic condtions. If the assumption 
holds that DMC is not capable of forming crosslinks in DNA, the implication is that a 
monoadduct of DMC is responsible for the cytotoxicity of this compound, and that more of 
these lesions are generated under hypoxic conditions. 
The UV5 cells exhibited intermediate sensitivity towards both MC and DMC. 
Because the UV5 strain is capable of repairing crosslinks, but not removal of large 
monoadducts, the data reported here support the theory that monoadducts play an important 
role in cell killing. Its intermediate response can be interpreted as partial recovery by its 
ability to repair crosslinks. Nonetheless, the fact that both the UV4 and UV5 lines, two 
substrains which have the inability to remove bulky monoadducts, have demonstrated 
increased sensitivity to DMC when compared to the wild-type strain AA8, strongly 

suggests that another lesion, most likely a monoadduct, contributes to the lethal activity of 
the mitomycins. 
Furthermore, in these four cell lines treatments with either MC or DMC have 
resulted in similar outcomes, providing additional support for the hypothesis that the 
crosslinks themselves may not solely account for the cytotoxic nature of the mitomycins. 
In fact, after Iyer and Szybalski hypothesized that the mitomycins were bifunctionally 
masked alkylating agents, there was speculation as to whether or not the aziridine ring and 
the carbamoyl groups were essential to account for their biological activity. Kinoshita and 
colleagues have analyzed and compared the 10-acyloxy derivatives of the 
decarbamoylmitosane and decarbamoylmitosene to the mitosane and mitosene containing 
the carbamoyl group (Kinoshita et al., 1981). Their data indicate that these compounds 
exhibit substantial antibacterial activity, suggesting that the carbamoyl group at the C-10" 
position of mitomycin C is not of significance, at least with respect to the antibacterial 
activity of the compound. 
Two other research groups have reported results which further question the 
importance of the cross-linking action of the mitomycins. First, a critical experiment by 
Carrano and co-workers used Chinese hamster ovary cells to compare the ability of MC 
and DMC to induce sister-chromatid exchanges [SCEs], a sensitive and quantitative assay 
used to measure genetic alteration. DMC was actually found to be more effective than MC 
in inducing SCEs, leading to the proposal that the DNA-interstrand crosslink is not the 
major lesion responsible for inducing SCEs in CHO cells but may in fact confer lethality 
beyond that from monofunctional alkylation (Carrano et al., 1979). Doit and his 
colleagues have also investigated the relationship between interstrand crosslinks and 
cytotoxicity in dose-response studies using MC. They raise the possibility that MC's 
impressive ability to produce cross-links could potentially prevent the detection of DNA- 
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strand breaks which are produced simultaneously by mechanisms involving quinone¬ 
generated oxygen free radicals, but which are not identifiable by current methods (Dorr et 
al., 1985). 
Due to the short-lived existence of the active form of MC, the DNA-drug complex 
has been difficult to isolate. As a consequence, identification and isolation of the lesions 
produced has been done primarily through manipulation of chemical systems. In their 
earlier studies on the bifunctional alkylating ability of mitomycin C, Tomasz and co¬ 
workers found that the initial monofunctional step of DNA binding consistently occurs at 
the C-l position of MC (Tomasz et al., 1988). The bifunctional activation of MC has been 
proposed to subsequently occur at the C-10 position, and the product distribution between 
monofunctional and bifunctional adduct formation is thought to depend on the rate of 
product formation rather than on the redox potentials. Although preferential crosslinking 
by MC in hypoxia would have been an attractive model to account for the differential 
toxicity in aerobic and anaerobic environments, current studies in cellular systems reveal 
that fully bifunctional activation of MC can also occur under aerobic conditions (Tomaz et 
al., 1987; Chowdary & Tomasz, 1987). This further supports the possibility that, 
although MC is capable of crosslinking DNA, other entities may also produce toxic effects. 
Several adducts have successfully been isolated from additional chemical studies. 
One monoadduct, interestingly, has been reported to be common in the pathways by which 
both MC and DMC appear to exert their cytotoxic effects (Tomasz et al, 1988a,b). 
Furthermore, both DMC and MC have been shown to exhibit the same 5'-CG specificity in 
DNA interaction (Kumar et al, 1992; Tomasz et al., 1988b). Crosslinks generally have 
been considered to be more lethal than the monofunctional adducts, because crosslinkage 
results in an irreversible block to DNA replication. However, it has also been hypothesized 
that perhaps after the monoalkylation step, the specific orientation of the monoadduct. 

namely with the C-10" position extending in the 5'-direction, may be critical in inhibiting 
DNA synthesis (Kumar et al., 1992; Small et al., 1976; Mercado & Tomasz, 1972; 
Kinoshita et al., 1971). In their studies using synthetic oligonucleotides reacted with 
mitomycin C under chemical conditions which restrict MC to monofunctional alkylating 
activity, Kumar and colleagues have shown that there is site selectivity in the 
monoalkylation of guanine, particularly in the 5'-GCG sequence. It is currently thought 
that this specificity is related to thermodynamic stability. Molecular modeling has 
supported the notion of specificity in the orientation of the compound, and from these 
observations one can hypothesize that perhaps the initial alkylation of MC, which appears 
to be identical to the action of DMC, plays a more significant role in damaging the structural 
integrity of DNA than was previously thought. 
Tomasz and colleagues have recently been working with site-specifically modified 
oligonucleotides which were synthesized to contain either of the two identified MC-DNA 
monoadducts. Interestingly, their data suggest that the monoadducts of MC are strong 
enough blocks of replication to be potentially lethal lesions in vivo (Basu et al., 1993). 
Molecular modeling studies indicate that a MC monoadduct fits snuggly into the minor 
groove of the duplex B-DNA, but it has also been postulated that the unique noncovalent, 
hydrogen-bonding capacities of the mitomycin-DNA interaction creates a 
thermodynamically stable, distorted structure at the replication fork, resulting in a 
polymerase block and hence termination of DNA synthesis. More specifically, the two 
polar functional groups of the bound MC, i.e. the 2"-NH3 and 10"-carbamate, have been 
identified as the main interactive elements. Experiments on DMC reveal that its 10"-OH 
group possesses similar properties. It is now known that both MC and DMC produce a 
common monoadduct, and it is tempting to speculate that this product could in fact be 
responsible for the cytotoxicity of the mitomycins. 
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Recently, the availability of [6-CH3-3H]-mitomycin C has made it possible to 
follow the processing of MC in cellular systems. This is considered to be the most direct 
method for detecting and identifying DNA adducts formed in intact cells. The lesions that 
have been isolated, both mono- and bis-adducts, were identified to be identical to the ones 
found in the chemical systems (Bizanek et al., 1993). When radiolabelled DMC becomes 
available, this will undoubtedly aid in determining whether the lesions produced by DMC 
in cellular systems correspond to those found in chemical systems. In addition, more 
extensive comparisons can be made between the lesions produced by MC and DMC /;7 
vivo. 
It is also necessary to evaluate the biological response triggered by these structural 
modifications. One consideration is the possibility that DMC may form crosslinks in 
biological systems which have not been producible under chemical conditions. Due to the 
complex nature of the cellular environment, it is reasonable to postulate that certain cellular 
components, i.e. enzymes and cofactors, could facilitate the formation of crosslinks which 
have yet to be found with chemical reaction systems (Bizanek et al., 1993; Rockwell, 
1986). Vos and Hanawalt have developed a system, referred to as the RAGE technique, 
that can been used to detect DNA crosslinks in cellular systems. This technique has been 
utilized to study psoralen, a furocoumarin which is known to intercalate DNA and to form 
covalent adducts with pyrimidine bases when exposed to near-ultraviolet light (Vos & 
Hanawalt, 1988; Misra & Vos, 1993). After exposure of the DHFR gene in cultured 
human cells with 4'-hydroxymethyl-4,5',8-trimethylpsoralen [HMT], the DNA is rapidly 
denatured and electrophorectically separated on agarose gel. Southern hybridization is then 
performed in order to quantify the level of cross-linking in the DNA samples. This method 
is presently being modified for use in investigating the possibility of crosslink formation by 
DMC in EMT6 cells (P. Glazer, personal communication). The results of this study will. 

hopefully, provide further insight into the mechanisms by which the mitomycins produce 
their cytotoxic actions. 
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Clinical Use of Mitomycin C 
Regions within tumors have transient or persistent deprivation in perfusion, 
resulting in the development of hypoxia, acidity, and nutritional deficits (Rockwell, 1992; 
Thomlinson & Gray, 1955). It has been well established that solid tumors in experimental 
animal tumors contain hypoxic cells which limit their curability (Kennedy et al., 1980). 
Recent advancements in laboratory techniques combined with the ever increasing fund of 
knowledge have resulted in providing more direct evidence for hypoxia in solid tumors, 
particularly in human neoplasms (Rockwell, 1992). Unlike chemotherapy, which can 
confront resistance and tumor recurrence from the cytogenetic alterations produced after 
drug treatment, radiotherapy does not appear to be dramatically affected by genetic changes 
(Rockwell, 1992; Deacon et al., 1984). The cellular environment, however, does 
markedly alter neoplastic response to radiation, with hypoxia inducing resistance to this 
treatment modality (Rockwell, 1992; Vaupel, 1989). 
Due to the existence of radio-resistant cell populations in solid tumors, there has 
been substantial interest by laboratory and clinical investigators in developing agents which 
circumvent the protective effect of hypoxia. Oxygen, even at low concentrations, has been 
demonstrated to act as a radiosensitizer (Gray et al., 1953). The half-maximum for 
radiosensitization occurs at about 3 torr, and the curve plateaus at oxygen tensions (PO2) of 
approximately 20-40 torr, which is the oxygen tension found in venous blood. Because 
normal tissue is usually well aerated, most normal tissues are fully, or almost completely, 
sensitive to radiation. With the rationale to enhance the effects of radiotherapy on hypoxic 
cells in solid tumors while minimizing its effects on normal tissue, the use of hypoxia- 
directed drugs such as mitomycin C have been studied both in the laboratory as well as the 
clinical research settings. 

Mitomycin C was first used as an adjunct to radiotherapy in head and neck cancer 
treatment at the Yale Comprehensive Cancer Center (Weissberg et al., 1989). In their first 
randomized clinical trial of 120 patients with biopsy-proven squamous cell carcinoma of the 
head and neck, the 5-year acturarial local recurrence-free survival was significantly better in 
the radiation therapy plus mitomycin C group as compared to the group treated with 
radiation alone (87% and 66%, respectively, p < 0.02). Hence the use of this alkylating 
agent appears to improve local tumor control in patients with tumors of the oral cavity, 
oropharynx, larynx, hypopharynx, and nasopharynx, thereby producing therapeutic gain. 
More recently, clinical trials in Toronto using mitomycin C as an adjunct to 5- 
fluorouracil plus radiotherapy in the treatment of carcinomas of the cervix and the anal canal 
have demonstrated improvement in local control with MC, as compared to treatment 
without mitomycin in the regimen (Rockwell, 1992; Thomas et al., 1990). Other clinical 
applications of mitomycin C are also underway. 

Conclusion 
Mitomycin C is an interesting compound in many respects. It is capable of 
exhibiting antimicrobial as well as antitumor activity. Activation is required before it can 
produce lethal effects. Furthermore it possesses the ability to cross-link DNA in addition to 
forming monoadducts. The precise mechanism of its ability to produce cytotoxicity, 
however, remains to be solved. Studies on its analogue decarbamoyl mitomycin C, 
reported here, seem to indicate that the primary cytotoxic lesion may in fact be a 
monoadduct. 
The mitomycins have been regarded as a challenging structure-activity problem. In 
cellular systems, factors such as oxygenation, pH, and cell proliferation patterns need to be 
taken into account (Rockwell, 1983), as well as the state of differentiation of cells, growth 
fraction, and intracellular communication (Sutherland et al., 1970). Other factors that need 
to be taken into account include the rate of transport, the intracellular location of activating 
enzymes, the rate of drug inactivation, intracellular pH, and the cellular capacity to repair 
drug-induced damage (Sartorelli, 1988). The issue of physiologic, metabolic, and 
environmental alterations which accompany hypoxia in solid neoplasms also needs to be 
addressed (Kennedy et al., 1980). 
Thus studying the cytotoxic effects of the mitomycins requires acknowledging the 
complexity in the interaction between mitomycin C and cells. New avenues have been 
considered which in the future may facilitate the elucidation of the mechanism of action of 
this drug. Studies using the RAGE technique to separate chemically cross-linked and un¬ 
cross-linked fragments of DNA are presently under way. In the future radiolabelled 
decarbamoyl mitomycin C could also provide useful information in understanding the 
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